During the past decade, Samara Regional Clinical Cardiology Dispensary n.a. Polyakov conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samara Regional Clinical Cardiology Dispensary n.a. Polyakov" #1 collaborator was "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Samara Regional Clinical Cardiology Dispensary n.a. Polyakov" are "Carcinoma, Renal Cell" (1 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials), "Heart Failure" (1 trials) and "Muscle-invasive Bladder Cancer" (1 trials). Many other conditions were trialed in "Samara Regional Clinical Cardiology Dispensary n.a. Polyakov" in a lesser frequency.

Most popular intervention types in "Samara Regional Clinical Cardiology Dispensary n.a. Polyakov" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atezolizumab" (2 trials), "Cabozantinib" (1 trials), "Finerenone (BAY94-8862)" (1 trials) and "Vericiguat (BAY1021189) 2.5 mg, 5 mg or 10 mg IR tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samara Regional Clinical Cardiology Dispensary n.a. Polyakov" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Samara Regional Clinical Cardiology Dispensary n.a. Polyakov". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Samara Regional Clinical Cardiology Dispensary n.a. Polyakov, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Samara Regional Clinical Cardiology Dispensary n.a. Polyakov, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Samara Regional Clinical Cardiology Dispensary n.a. Polyakov has several departments that took part in Clinical trials: "SBI of Healthcare Samara Regional Clinical Oncology Dispensary" - 38 trials